A detailed history of Boxer Capital, LLC transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Boxer Capital, LLC holds 1,708,187 shares of PRLD stock, worth $1.64 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,708,187
Previous 2,568,287 33.49%
Holding current value
$1.64 Million
Previous $9.79 Million 63.87%
% of portfolio
0.19%
Previous 0.54%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.07 - $6.37 $1.78 Million - $5.48 Million
-860,100 Reduced 33.49%
1,708,187 $3.54 Million
Q4 2023

Feb 14, 2024

BUY
$1.69 - $4.37 $123,824 - $320,185
73,269 Added 2.94%
2,568,287 $11 Million
Q2 2023

Aug 14, 2023

BUY
$4.45 - $8.12 $7.99 Million - $14.6 Million
1,795,971 Added 256.92%
2,495,018 $11.2 Million
Q1 2023

May 15, 2023

BUY
$4.58 - $7.34 $3.2 Million - $5.13 Million
699,047 New
699,047 $3.99 Million

Others Institutions Holding PRLD

About Prelude Therapeutics Inc


  • Ticker PRLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,369,200
  • Market Cap $34.9M
  • Description
  • Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...
More about PRLD
Track This Portfolio

Track Boxer Capital, LLC Portfolio

Follow Boxer Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boxer Capital, LLC with notifications on news.